FDA and CDC Update Guidelines Amid Omicron + Life Science Trends for 2022

In the first episode of 2022, Ayesha provided updates on Omicron and COVID-19 vaccine boosters. The FDA expanded authorization of booster doses of Pfizer’s COVID-19 vaccine to youth between 12 and 15 years of age, a third dose for immunocompromised children between five and 11 years old and a shorter wait time to get a booster for individuals 12 and older. Meanwhile, the CDC reduced isolation and quarantine periods by half to five days. The team discussed the implication of these updates and despite the direness of the current situation, expressed hope in seeing the pandemic finally end.

Ayesha also discussed some of the predicted trends in the life sciences in 2022. These include the continued promise of RNA-based vaccines and therapeutics like RNA editing for the treatment of various conditions including rare genetic diseases. Digital transformation in healthcare is another significant trend that will continue in 2022. Tools like wearable technologies, electronic data capture and integration of AI approaches are enabling the digital transformation of healthcare to help improve and revolutionize patient care.

Read the full articles here: 

Key Trends in the Life Sciences to Look Forward to in 2022

For more life science and medical device content, visit the Xtalks Vitals homepage.

Follow Us on Social Media

Twitter: @Xtalks
Instagram: @Xtalks
Facebook: https://www.facebook.com/Xtalks.Webinars/
LinkedIn: https://www.linkedin.com/company/xtalks-webconferences
YouTube: https://www.youtube.com/c/XtalksWebinars/featured